Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




The Storm After the Calm: South Africa Moves to a Primary Healthcare Model
Link ID 5158
Title The Storm After the Calm: South Africa Moves to a Primary Healthcare Model
Url http://www.medscape.com/viewarticle/572044?src=rss
Description A nurse visits South Africa, a country struggling to overhaul its healthcare system, and vividly describes her experiences.
Medscape Nurses
Category Articles > Business of Medicine
Keywords
Date Apr 25, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. PPIs May Be Cost-Effective in Some Patients Taking Prophylactic Aspirin
  At over-the-counter cost, proton pump inhibitors are cost-effective in average-risk patients taking low-dose aspirin for secondary prevention of coronary heart disease. Medscape Medical News
Category:   Articles > Business of Medicine


2. China Warns Against Complacency About Tuberculosis
  China is not doing enough to fight tuberculosis and should not rest on its laurels with successes achieved to date, the health minister warned in an official newspaper on Wednesday. Reuters Health Information
Category:   Articles > Business of Medicine


3. FDA Approves Smaller, Quieter Left Ventricular Assist Device
  The more compact size means the device can be used in women and in men with trunk sizes too small to be implanted with earlier, larger models. Heartwire
Category:   Articles > Business of Medicine


4. A Reader and Author Respond to "ePatients: Engaging Patients in Their Own Care"
  Online patient communities are a valuable resource for ePatients on their journey through illness and wellness.
The Medscape Journal of Medicine
Category:   Articles > Business of Medicine


5. Glaxo Gets Formal EU Okay for Breast Cancer Drug
  GlaxoSmithKline Plc has received formal European marketing authorisation for its new breast cancer pill Tyverb, the drugmaker said on Thursday. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS